Exercise-induced inhibition of angiotensin II vasoconstriction in human thigh muscle

Journal of Physiology

Volumn 577, Issue 2, 2006, Pages 727-737

  Brothers, R Matthew ^a   Haslund, Mads L ^b   Wray, D Walter ^a   Raven, Peter B ^a   Sander, Mikael ^b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; PHENYLEPHRINE; ALPHA 1 ADRENERGIC RECEPTOR;

ADULT; ARTERY DIAMETER; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DOPPLER FLOWMETRY; EXERCISE PHYSIOLOGY; FEMORAL ARTERY FLOW; HEART VENTRICLE FILLING; HUMAN; HUMAN EXPERIMENT; MALE; METABOLIC INHIBITION; MUSCLE BLOOD FLOW; NORMAL HUMAN; PRIORITY JOURNAL; THERMODILUTION; ADRENERGIC ACTIVITY; CONTROLLED STUDY; EXTENSOR MUSCLE; FEMORAL VASCULAR CONDUCTANCE; MUSCLE EXERCISE; MUSCLE METABOLISM; REST; STEADY STATE; THIGH; VASOCONSTRICTION; WORKLOAD;

ADRENERGIC ALPHA-AGONISTS; ADULT; ANGIOTENSIN II; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXERCISE; FEMORAL ARTERY; HEART RATE; HUMANS; MALE; MUSCLE, SKELETAL; PHENYLEPHRINE; REFERENCE VALUES; REGIONAL BLOOD FLOW; THIGH; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 33751330698     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.113977     Document Type: Article

References (57)

1. Andersen P & Saltin B (1985). Maximal perfusion of skeletal muscle in man. J Physiol 366, 233-249.
2. Baan J Jr, Chang PC, Vermeij P, Pfaffendorf M & Van Zwieten PA (1996). Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers. Cardiovasc Res 32, 973-979.
3. Blanchet M, Sheppard R, Racine N, Ducharme A, Curnier D, Tardif JC, Sirois P, Lamoureux MC, De Champlain J & White M (2005). Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure. Am J Physiol Heart Circ Physiol 149, e1-7.
4. Bocqueraz O, Koulmann N, Guigas B, Jimenez C & Melin B (2004). Fluid-regulatory hormone responses during cycling exercise in acute hypobaric hypoxia. Med Sci Sports Exerc 36, 1730-1736.
5. Buckwalter JB & Clifford PS (1999). α-Adrenergic vasoconstriction in active skeletal muscles during dynamic exercise. Am J Physiol Heart Circ Physiol 277, H33-H39.
6. Buckwalter JB, Hamann JJ & Clifford PS (2003). Vasoconstriction in active skeletal muscles: A potential role for P2X purinergic receptors? J Appl Physiol 95, 953-959.
7. Buckwalter JB, Hamann JJ, Kluess HA & Clifford PS (2004 b). Vasoconstriction in exercising skeletal muscles: A potential role for neuropeptide Y? Am J Physiol Heart Circ Physiol 287, H144-H149.
8. Buckwalter JB, Taylor JC, Hamann JJ & Clifford PS (2004 a). Role of nitric oxide in exercise sympatholysis. J Appl Physiol 97, 417-423.
9. Burcher E & Garlick D (1973). Antagonism of vasoconstrictor responses by exercise in the gracilis muscle of the dog. J Pharmacol Exp Ther 187, 78-85.
10. Chang PC, Grossman E, Kopin IJ, Goldstein DS, Folio CJ & Holmes C (1995). On the existence of functional angiotensin II receptors on vascular sympathetic nerve terminals in the human forearm. J Hypertens 13, 1275-1284.
11. Cheng C-P, Ukai T, Onishi K, Ohte N, Suzuki M, Zhang Z-S, Cheng H-J, Tachibana H, Igawa A & Little WC (2001). The role of ang II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure. Am J Physiol Heart Circ Physiol 280, H1853-H1860.
12. Clemson B, Gaul Lawrence Gubin SS, Campsey DS, McConville J, Nussberger J & Zelis R (1994). Prejunctional angiotensin II receptors. facilitation of norepinephrine release in the human forearm. J Clin Invest 93, 684-691.
13. Cox SL, Trendelenburg AU & Starke K (1999). Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues. Br J Pharmacol 127, 1256-1262.
14. Dinenno FA, Eisenach JH, Dietz NM & Joyner MJ (2002). Post-junctional alpha-adrenoceptors and basal limb vascular tone in healthy men. J Physiol 540, 1103-1110.
15. Dinenno FA & Joyner MJ (2003). Blunted sympathetic vasoconstriction in contracting skeletal muscle of healthy humans: Is nitric oxide obligatory? J Physiol 533 1, 281-292.
16. Dinenno FA & Joyner MJ (2004). Combined NO and PG inhibition augments alpha-adrenergic vasoconstriction in contracting human skeletal muscle. Am J Physiol Heart Circ Physiol 287, H2576-H2584.
17. Faber JE (1988). In situ analysis of alpha-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation. Circ Res 62, 37-50.
18. Gohla A, Schultz G & Offermans S (2000). Role for G12/G13 in agonist-induced vascular smooth muscle cell contraction. Circ Res 87, 221-227.
19. Goldsmith SR, Garr M & McLaurin M (1998). Regulation of regional norepinephrine spillover in heart failure: The effect of angiotensin II and beta-adrenergic agonists in the forearm circulation. J Card Fail 4, 305-310.
20. Hansen J, Sander M & Thomas GD (2000). Metabolic modulation of sympathetic vasoconstriction in exercising skeletal muscle. Acta Physiol Scand 168, 489-503.
21. Hansen J, Sayad D, Thomas GD, Clarke GD, Peshock RM & Victor RG (1999). Exercise-induced attenuation of alpha-adrenoceptor mediated vasoconstriction in humans: Evidence from phase-contrast MRI. Cardiovasc Res 41, 220-228.
22. Hartshorne DJ (1998). Myosin phosphatase: Subunits and interactions. Acta Physiol Scand 164, 483-493.
23. 2 uptake in rhythmically contracting human forearm muscles. Am J Physiol Heart Circ Physiol 263, H1078-H1083.
24. Keller DM, Ogoh D, Green S, Olivencia-Yurvati A & Raven PB (2004). Inhibition of Katp channel activity augments baroreflex mediated vasoconstriction in exercising skeletal muscle. J Physiol 561, 273-282.
25. Kinugawa T, Endo A, Kato M, Kato T, Ahmmed GU, Omodani H, Osaki S, Ogino K, Hisatome I, Miyakoda H, Fujimoto Y, Yoshida A & Shigemasa C (1997). Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension. Cardiology 88, 238-245.
26. Kinugawa T, Ogino K, Kitamura H, Saitoh M, Omodani H, Osaki S, Hisatome I & Miyakoda H (1996). Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure. Am J Med Sci 312, 110-117.
27. Krum H, Lambert E, Windebank E, Campbell DJ & Esler M (2006). Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol 290, H1706-H1712.
28. Leuenberger U, Gaul L, Noack H, Gubin S & Zelis R (1996). Angiotensin-converting enzyme inhibition and the norepinephrine spillover response to dynamic exercise. J Appl Physiol 81, 1138-1142.
29. Mansfield D, Kaye DM, Brunner La Rocca H, Solin P, Esler MD & Naughton MT (2003). Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 107, 1396-1400.
30. McEniery CM, Wilkinson IB, Jenkins DG & Webb DJ (2002). Endogenous endothelin-1 limits exercise-induced vasodilation in hypertensive humans. Hypertension 40, 202-206.
31. Nielsen S, Halliwill JR, Joyner MJ & Jensen MD (2004). Vascular response to angiotensin II in upper body obesity. Hypertension 44, 435-441.
32. Paxton WG, Runge M, Horaist C, Cohen C, Alexander RW & Bernstein KE (1993). Immunohistochemical localization of rat angiotensin II AT1 receptor. Am J Physiol 264, F989-F995.
33. Radegran G (1997). Ultrasound Doppler estimates of femoral artery blood flow during dynamic knee extensor exercise in humans. J Appl Physiol 83, 1383-1388.
34. Remensynder JP, Mitchell JH & Sarnoff SJ (1962). Functional sympatholysis during muscular activity. Circ Res 11, 370-380.
35. 2-adrenergic vasoconstriction is blunted in contracting human muscle. J Physiol 547, 971-979.
36. Rosenmeier JB, Hansen J & Gonzalez-Alonso J (2004). Circulating ATP-induced vasodilation overrides sympathetic vasoconstrictor activity in human skeletal muscle. J Physiol 558, 351-365.
37. Sander M, Chavoshan B, Harris SA, Iannaccone ST, Stull JT, Thomas GD & Victor RG (2000). Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne's muscular dystrophy. Proc Natl Acad Sci U S A 97, 13818-13823.
38. Saris JJ, van Dijk MA, Kroon I, Schalekamp MA & Dauser AH (2000). Functional importance of angiotensin-converting-enzyme-dependent in situ angiotensin II generation in the human forearm. Hypertension 35, 764-768.
39. Schlaich MP, Kaye DM, Lambert E, Hastings J, Campbell DJ, Lambert G & Esler MD (2005). Angiotensin II and norepinephrine release: interaction and effects on the heart. J Hypertens 23, 1077-1082.
40. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A & Esler MD (2004). Sympathetic augmentation in hypertension: Role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43, 169-175.
41. Seasholtz TM, Gurdal H, Wang H-Y, Johnson MD & Friedman E (1997). Desensitization of norepinephrine receptor function is associated with G protein uncoupling in the rat aorta. Am J Physiol Heart Circ Physiol 42, H279-H285.
42. Staessen J, Fagard R, Hespel P, Lijnen P, Vanhees L & Amery A (1987). Plasma renin system during exercise in normal men. J Appl Physiol 63, 188-194.
43. Stull JT, Lin PJ, Krueger JK, Trewhella J & Zhi G (1998). Myosin light chain kinase: Functional domains and structural motifs. Acta Physiol Scand 164, 471-482.
44. Thomas GD, Hansen J & Victor RG (1994). Inhibition of alpha 2-adrenergic vasoconstriction during contraction of glycolytic, not oxidative, rat hindlimb muscle. Am J Physiol Heart Circ Physiol 266, H920-H929.
45. Thomas GD, Hansen J & Victor RG (1997). ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Clin Invest 99, 2602-2609.
46. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT & Victor RG (1998). Impaired metabolic modulation of α-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A 95, 15090-15095.
47. Thomas GD & Victor RG (1997). Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Physiol 506, 817-826.
48. Thomas GD, Zhang W & Victor RG (2001). Impaired modulation of sympathetic vasoconstriction in contracting skeletal muscle of rats with chronic myocardial infarctions: Role of oxidative stress. Circ Res 88, 816-823.
49. Tidgren B, Hjemdahl P, Theodorsson E & Nussberger J (1991). Renal neurohormonal and vascular responses to dynamic exercise in humans. J Appl Physiol 70, 2279-2286.
50. Trendelenburg AU, Meyer A, Klebroff W, Guimaraes S & Starke K (2003). Crosstalk between presynaptic angiotensin receptors, bradykinin receptors and alpha 2-autoreceptors in sympathetic neurons: A study in alpha 2-adrenoceptor-deficient mice. Br J Pharmacol 138, 1389-1402.
51. Tschakovsky ME, Sujirattanawimol K, Ruble SB, Valic Z & Joyner MJ (2002). Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle? J Physiol 541, 623-635.
52. VanTeeffelen JW & Segal SS (2003). Interaction between sympathetic nerve activation and muscle fibre contraction in resistance vessels of hamster retractor muscle. J Physiol 550, 563-574.
53. Vicaut E, Montalescot G, Hou X, Stucker O & Teisseire B (1989). Arteriolar vasoconstriction and tachyphylaxis with intra-arterial angiotensin-II. Microvasc Res 37, 28-41.
54. Victor RG, Pryor SL, Secher NH & Mitchell JH (1989). Effects of partial neuromuscular blockade on sympathetic nerve responses to static exercise in humans. Circ Res 65, 468-476.
55. Victor RG, Secher NH, Lyson T & Mitchell JH (1995). Central command increases muscle sympathetic nerve activity during intense intermittent isometric exercise in humans. Circ Res 76, 127-131.
56. Wray DW, Fadel PJ, Smith ML, Raven PB & Sander M (2004). Inhibition of α-adrenergic vasoconstriction in exercising human thigh muscles. J Physiol 555, 545-563.
57. Yousufuddin M, Shamim W, Chambers JS, Henein M, Amin FR, Anker SD, Kemp M, Hooper J & Coats AJS (2000). Superiority of endothelin-1 over norepinephrine in exercise-induced alterations of the conduit artery tone of the non-exercised arm in patients with chronic heart failure. Int J Cardiol 73, 15-25.